An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Top results in this bookTable of Contents
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
Ustekinumab (Stelara) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.
Budesonide (Cortiment MMX) [Internet].
Upadacitinib (Rinvoq): CADTH Reimbursement Review: Therapeutic area: Ulcerative colitis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.
Entyvio (Vedolizumab) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Dec.
Golimumab (Simponi) (Subcutaneous Injection): Adult Patients with Moderately to Severely Active Ulcerative Colitis Who Have Had an Inadequate Response to, or Have Medical Contraindications for, Conventional Therapies [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Nov.
Risankizumab (Skyrizi): CADTH Reimbursement Review: Therapeutic area: Crohn disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Aug.
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
Archer R, Tappenden P, Ren S, et al.
Southampton (UK): NIHR Journals Library; 2016 May. (Health Technology Assessment, No. 20.39.)
Clinical Review Report: adalimumab (Humira) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Apr.
Pharmacoeconomic Review Report: Budesonide (Jorveza): (AVIR Pharma Inc.): Indication: For the induction of clinicopathologic remission in adults with eosinophilic esophagitis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Dec.
Clinical Review Report: Tofacinitib (Xeljanz): (Pfizer Canada Inc.): Indication: For the treatment of adult patients with moderately to severely active ulcerative colitis (UC) with an inadequate response, loss of response, or intolerance to either conventional UC therapy or a tumour necrosis factor alpha inhibitor [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar.
Mirikizumab (Omvoh): CADTH Reimbursement Review: Therapeutic area: Ulcerative colitis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Feb.
Ozanimod (Zeposia): CADTH Reimbursement Review: Therapeutic area: Ulcerative colitis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Feb.
The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition.
Carreras E, Dufour C, Mohty M, et al., editors.
Cham (CH): Springer; 2019.
Clinical effectiveness and cost-effectiveness of elemental nutrition for the maintenance of remission in Crohn’s disease: a systematic review and meta-analysis.
Tsertsvadze A, Gurung T, Court R, et al.
Southampton (UK): NIHR Journals Library; 2015 Mar. (Health Technology Assessment, No. 19.26.)
Non-Hodgkin's Lymphoma: Diagnosis and Management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 52.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on